FDA Withdraws Approval of New Animal Drug Application for Bacitracin Zinc

Summary

The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA) for a bacitracin zinc Type A medicated article, as part of an amendment to the animal drug regulations published in the Federal Register.